Chiang, Anne C. http://orcid.org/0000-0002-2111-4694
Fernandes, Ancilla W.
Pavilack, Melissa
Wu, Jennifer W.
Laliberté, François
Duh, Mei Sheng
Chehab, Nabil
Subramanian, Janakiraman
Funding for this research was provided by:
AstraZeneca US (Not applicable)
Article History
Received: 25 October 2019
Accepted: 5 April 2020
First Online: 28 April 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The New England Independent Review Board (NEIRB) determined that this research activity was exempt from NEIRB review, under the following category:Research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if the investigator records the information in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects.The Copernicus Group Institutional Review Board approved the waiver of informed consent prior to initiation of this study.
: Not applicable.
: ACC has participated in advisory boards for, or received consultancy fees or research grants from AstraZeneca, AbbVie, Bristol-Myers Squibb, Genetech/Roche, and Lilly. AWF, MP, and NC are employees of AstraZeneca. JWW, FL, and MSD are employees of Analysis Group, Inc., a consulting company that has received research funds from AstraZeneca. JS has received consulting fees, speaking fees and research grants from AstraZeneca, Biocept, Boehringer-Ingelheim, Lilly, Paradigm, and Pfizer.